REVIEW article
Front. Immunol., 20 August 2021
Sec. Cancer Immunity and Immunotherapy
Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.699746
RETRACTED: Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
- ER
Ehsan Razeghian 1
- WS
Wanich Suksatan 2
- HS
Heshu Sulaiman Rahman 3,4
- DO
Dmitry O. Bokov 5,6
- WK
Walid Kamal Abdelbasset 7,8
- AH
Ali Hassanzadeh 9
- FM
Faroogh Marofi 10
- MY
Mahboubeh Yazdanifar 11
- MJ
Mostafa Jarahian 12*
1. Human Genetics Division, Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology (NIGEB), Tehran, Iran
2. Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand
3. Department of Physiology, College of Medicine, University of Suleimanyah, Suleimanyah, Iraq
4. Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaimaniyah, Iraq
5. Institute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russia
6. Laboratory of Food Chemistry, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow, Russia
7. Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia
8. Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt
9. Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
10. Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran
11. Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States
12. Toxicology and Chemotherapy Unit (G401), German Cancer Research Center, Heidelberg, Germany
Summary
Citation
Razeghian E, Suksatan W, Sulaiman Rahman H, Bokov DO, Abdelbasset WK, Hassanzadeh A, Marofi F, Yazdanifar M and Jarahian M (2021) RETRACTED: Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges. Front. Immunol. 12:699746. doi: 10.3389/fimmu.2021.699746
Received
24 April 2021
Accepted
05 August 2021
Published
20 August 2021
Volume
12 - 2021
Edited by
Fabrizio Mattei, National Institute of Health (ISS), Italy
Reviewed by
Michael Kalafatis, Cleveland University, United States; Thomas Griffith, University of Minnesota Twin Cities, United States
Updates
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.